Back to MOLN Stock Lookup

(MOLN) –

Jun 21, 2021 07:28 AM UPDATE: H.C. Wainwright Assumes Molecular Partners (MOLN) at Buy
Jun 16, 2021 05:25 PM Form 424B4 MOLECULAR PARTNERS AG
Jun 16, 2021 11:17 AM Molecular Partners AG (MOLN) IPO Opens Modestly Lower
Jun 16, 2021 06:04 AM Form EFFECT MOLECULAR PARTNERS AG
Jun 16, 2021 06:03 AM Form EFFECT MOLECULAR PARTNERS AG
Jun 15, 2021 10:17 AM Form CERT MOLECULAR PARTNERS AG
Jun 14, 2021 09:09 AM Form F-1/A MOLECULAR PARTNERS AG
Jun 14, 2021 09:06 AM Form FWP MOLECULAR PARTNERS AG Filed by: MOLECULAR PARTNERS AG
Jun 11, 2021 04:04 PM Form 8-A12B MOLECULAR PARTNERS AG
Jun 10, 2021 05:05 PM Form F-1/A MOLECULAR PARTNERS AG
Jun 9, 2021 12:02 PM Form F-6 MOLECULAR PARTNERS AG Filed by: Citibank,N.A./ADR
Jun 9, 2021 07:06 AM Form F-1/A MOLECULAR PARTNERS AG
May 12, 2021 05:10 PM Form F-1/A MOLECULAR PARTNERS AG
May 4, 2021 05:22 PM Form F-1/A MOLECULAR PARTNERS AG
Apr 22, 2021 05:29 PM Form F-1 MOLECULAR PARTNERS AG
Mar 17, 2020 04:00 AM Medicxi Bolsters and Expands Team with Senior Industry Leaders
Oct 14, 2019 06:13 AM Allergan (AGN), Molecular Partners Announce Late-Breaking Data from Phase 3 Studies of Investigational Abicipar pegol
Oct 11, 2019 07:40 PM Allergan and Molecular Partners Present Late-Breaking Data from Phase 3 Studies of Investigational Abicipar pegol in Neovascular Wet Age-Related Macular Degeneration
Sep 18, 2019 01:00 PM Divide & Conquer, Developing New Class of Cancer Therapeutics to Disrupt Cell-to-Cell Communication, Emerges from Stealth as New Paper by Co-Founder is Published in Nature
Sep 9, 2019 07:30 AM Allergan and Molecular Partners Announce Acceptance of U.S. FDA Biologics License Application and Validation of EMA Marketing Authorisation for Abicipar pegol in Patients with Neovascular (Wet) Age-re
Jul 18, 2019 07:00 PM Medicxi Closes a New €400m Fund (Medicxi III) to Power the Next Wave of Biopharma Entrepreneurs and Drug Hunters
Apr 2, 2019 07:05 AM Allergan (AGN) and Molecular Partners Announce Topline Safety Results from MAPLE study of Abicipar pegol
Apr 2, 2019 07:00 AM Allergan and Molecular Partners Announce Topline Safety Results from MAPLE study of Abicipar pegol
Dec 18, 2018 11:00 PM Amgen And Molecular Partners Announce Strategic Collaboration In Immuno-Oncology
Jul 19, 2018 08:02 AM Allergan (AGN), Molecular Partners Announce Two Positive Phase 3 Clinical Trials for Abicipar pegol 8 and 12-week Regimens for Treatment in Patients with Neovascular AMD
Jul 19, 2018 08:00 AM Allergan and Molecular Partners Announce Two Positive Phase 3 Clinical Trials for Abicipar pegol 8 and 12-week Regimens for the Treatment in Patients with Neovascular Age-Related Macular Degeneration
Sep 19, 2017 04:00 AM Moncef Slaoui Joins Medicxi
Jul 5, 2017 10:00 AM Diasome Pharmaceuticals, Inc. Receives Funding Led By Medicxi
Feb 2, 2016 01:00 AM Medicxi Ventures, Formerly Index Ventures Life Sciences, Launches as an Independent Venture Capital Firm and Announces Closing of a €210m Fund including GSK and Johnson & Johnson Innovation

Back to MOLN Stock Lookup